Evaluation of allogeneic haematopoietic stem cell transplantation and pre- and post-transplant therapy in high-risk patients with chronic myeloid leukaemia

被引：0
|
作者：
Oyekunle, A. [1 ]
Klyuchnikov, E. [1 ]
Kroeger, N. [1 ]
Zabelina, T. [1 ]
Ayuk, F. [1 ]
Wolschke, C. [1 ]
Bernhardt, F. [1 ]
Mueller, I. [1 ]
Zander, A. [1 ]
Bacher, U. [1 ]
机构：
[1] Clin Stem Cell Transplantat, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [31] Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for patients with high-risk hematologic malignancies
    Carella, A. M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S183 - S184
  • [32] Allogeneic stem cell transplantation in high-risk acute lymphoblastic leukaemia
    Guidi, S
    Bartolozzi, B
    Luti, V
    Lombardini, L
    Nozzoli, C
    Saccardi, R
    Vannucchi, A
    Ferrini, PR
    Bosi, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S217 - S217
  • [33] Factors affecting the curative effect of allogeneic stem cell transplantation in patients with high-risk chronic lymphocytic leukaemia
    Iori, A. P.
    Laurenti, L.
    Piciocchi, A.
    Severino, A.
    Chiusolo, P.
    Mauro, F. R.
    Torelli, G. F.
    Della Starza, I.
    Majolino, I.
    Locasciulli, A.
    Meloni, G.
    Sica, S.
    Leone, G.
    Foa, R.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S243 - S244
  • [34] Myeloablative allogeneic haematopoietic stem cell transplantation for 25 patients under 18 years of age with chronic myeloid leukaemia
    Nacer, R. Ahmed
    Benakli, M.
    Baazizi, M.
    Belhadj, R.
    Rahmoune, N.
    Mehdid, F.
    Harieche, F.
    Ouali, D. Ait
    Zerhouni, F.
    Hamladji, R. M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S383 - S384
  • [35] Imatinib mesylate for treatment of relapse after allogeneic haematopoietic stem cell transplantation for chronic myeloid leukaemia
    Arqueros, V
    Espigares, A
    Roman, J
    Martin, A
    Jimenez, A
    Fernandez, C
    Capote, M
    Molina, J
    Heiniger, A
    Torres, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S228 - S228
  • [36] Hypomethylating agent-based post-transplant strategies to maximize the outcome of high-risk acute myeloid leukemia after allogeneic stem cell transplantation
    Baek, Dong Won
    Kim, Juhyung
    Cho, Hee Jeong
    Moon, Joon Ho
    Sohn, Sang Kyun
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 959 - 969
  • [37] The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia
    Fiona Fernando
    Andrew J. Innes
    Simone Claudiani
    Angharad Pryce
    Chloe Hayden
    Jenny Byrne
    Paolo Gallipoli
    Mhairi Copland
    Jane F. Apperley
    Dragana Milojkovic
    Bone Marrow Transplantation, 2023, 58 : 826 - 828
  • [38] The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia
    Fernando, Fiona
    Innes, Andrew J.
    Claudiani, Simone
    Pryce, Angharad
    Hayden, Chloe
    Byrne, Jenny
    Gallipoli, Paolo
    Copland, Mhairi
    Apperley, Jane F.
    Milojkovic, Dragana
    BONE MARROW TRANSPLANTATION, 2023, 58 (07) : 826 - 828
  • [39] Haematopoietic stem cell transplantation for treatment of chronic myeloid leukaemia in childhood
    Suttorp, M
    Klöpper, K
    Hasenkamp, J
    BONE MARROW TRANSPLANTATION, 2001, 27 : S143 - S143
  • [40] Post-transplant flow cytometry MRD predicts relapse in AML and high risk MDS patients treated with allogeneic haematopoietic stem cell transplant
    Wood, H.
    Sanchez, K.
    Potter, V.
    Kulasekararaj, A.
    Yallop, D.
    Kassam, S.
    Ireland, R.
    Mufti, G.
    Dunlop, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 153 - 154
12345